BTG Wins Approval for Drug to Mitigate Toxic Cancer Medicine

Voraxaze is available in the US as part of a compassionate-use program under which the FDA allows patients with immediately life-threatening diseases access to alternative treatments on a case-by-case basis. The medicine brought in sales of $5.1 …
See all stories on this topic »